Cargando…
Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group
Molecular biomarker testing is the standard of care for non–small cell lung cancer (NSCLC) patients. In 2017, the Korean Cardiopulmonary Pathology Study Group and the Korean Molecular Pathology Study Group co-published a molecular testing guideline which contained almost all known genetic changes th...
Autores principales: | Chang, Sunhee, Shim, Hyo Sup, Kim, Tae Jung, Choi, Yoon-La, Kim, Wan Seop, Shin, Dong Hoon, Kim, Lucia, Park, Heae Surng, Lee, Geon Kook, Lee, Chang Hun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141968/ https://www.ncbi.nlm.nih.gov/pubmed/33966368 http://dx.doi.org/10.4132/jptm.2021.03.23 |
Ejemplares similares
-
Provisional Guideline Recommendation for EGFR Gene Mutation Testing in Liquid Samples of Lung Cancer Patients: A Proposal by the Korean Cardiopulmonary Pathology Study Group
por: Shin, Dong Hoon, et al.
Publicado: (2019) -
Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group
por: Shim, Hyo Sup, et al.
Publicado: (2013) -
Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group
por: Kim, Hyojin, et al.
Publicado: (2014) -
Usefulness of BRAF VE1 immunohistochemistry in non–small cell lung cancers: a multi-institutional study by 15 pathologists in Korea
por: Chang, Sunhee, et al.
Publicado: (2022) -
Correlation between maximal tumor diameter of fresh pathology specimens and computed tomography images in lung adenocarcinoma
por: Park, Chul Hwan, et al.
Publicado: (2019)